These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30639458)

  • 1. Projected impact, cost-effectiveness, and budget implications of rotavirus vaccination in Mongolia.
    Lusvan ME; Debellut F; Clark A; Demberelsuren S; Otgonbayar D; Batjargal T; Purevsuren S; Groman D; Tate J; Pecenka C
    Vaccine; 2019 Feb; 37(6):798-807. PubMed ID: 30639458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
    Anwari P; Debellut F; Pecenka C; Parwiz SM; Clark A; Groman D; Safi N
    Vaccine; 2018 Dec; 36(51):7769-7774. PubMed ID: 29107346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
    Patel HD; Roberts ET; Constenla DO
    Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
    Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
    Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of rotavirus vaccination in Albania.
    Ahmeti A; Preza I; Simaku A; Nelaj E; Clark AD; Felix Garcia AG; Lara C; Hoestlandt C; Blau J; Bino S
    Vaccine; 2015 May; 33 Suppl 1():A201-8. PubMed ID: 25919162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of the implementation of a National Immunization Program for rotavirus vaccination in a country with a low rotavirus gastroenteritis-related mortality: A South Korean study.
    Lee H; Park SY; Clark A; Debellut F; Pecenka C; Kim DS; Kim HM; Kim JH; Cho H; Kim AY; Lee M; Jung SY; Seong BL; Kang HY
    Vaccine; 2019 Aug; 37(35):4987-4995. PubMed ID: 31326252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
    Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
    Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
    Villanueva-Uy MET; Lam HY; Aldaba JG; Uy TMZ; Valverde HA; Silva MWT; Mooney J; Clark A; Pecenka C
    Vaccine; 2021 Nov; 39(48):7091-7100. PubMed ID: 34753614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study.
    Debellut F; Clark A; Pecenka C; Tate J; Baral R; Sanderson C; Parashar U; Kallen L; Atherly D
    Lancet Glob Health; 2019 Dec; 7(12):e1664-e1674. PubMed ID: 31708147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of ROTARIX and ROTAVAC.
    Debellut F; Jaber S; Bouzya Y; Sabbah J; Barham M; Abu-Awwad F; Hjaija D; Ramlawi A; Pecenka C; Clark A; Mvundura M
    PLoS One; 2020; 15(2):e0228506. PubMed ID: 32023295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
    Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
    PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A cost-effectiveness analysis on universal infant rotavirus vaccination strategy in China].
    Sun SL; Gao YQ; Yin J; Zhuang GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Feb; 37(2):238-42. PubMed ID: 26917523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of rotavirus vaccination in Mozambique.
    Lourenço Guimarães E; Chissaque A; Pecenka C; Clark A; Vaz B; Banze A; Canana N; Romão C; do Rosário Oliveira Martins M; de Deus N; Debellut F
    Vaccine; 2022 Aug; 40(36):5338-5346. PubMed ID: 35933279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.
    Javanbakht M; Moradi-Lakeh M; Yaghoubi M; Esteghamati A; Mansour Ghanaie R; Mahmoudi S; Shamshiri AR; Zahraei SM; Baxter L; Shakerian S; Chaudhri I; Fleming JA; Munier A; Baradaran HR
    Vaccine; 2015 May; 33 Suppl 1():A192-200. PubMed ID: 25919160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.
    Bar-Zeev N; Tate JE; Pecenka C; Chikafa J; Mvula H; Wachepa R; Mwansambo C; Mhango T; Chirwa G; Crampin AC; Parashar UD; Costello A; Heyderman RS; French N; Atherly D; Cunliffe NA;
    Clin Infect Dis; 2016 May; 62 Suppl 2(Suppl 2):S220-8. PubMed ID: 27059360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact and cost-effectiveness of rotavirus vaccination in Bangladesh.
    Pecenka C; Parashar U; Tate JE; Khan JAM; Groman D; Chacko S; Shamsuzzaman M; Clark A; Atherly D
    Vaccine; 2017 Jul; 35(32):3982-3987. PubMed ID: 28623028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
    De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
    Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of rotavirus vaccination in Kenya and Uganda.
    Sigei C; Odaga J; Mvundura M; Madrid Y; Clark AD; ;
    Vaccine; 2015 May; 33 Suppl 1():A109-18. PubMed ID: 25919149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
    Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
    Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi.
    Niyibitegeka F; Riewpaiboon A; Youngkong S; Thavorncharoensap M
    Vaccine; 2021 Feb; 39(8):1272-1282. PubMed ID: 33487467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.